publication venue for Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.. 64:631-642. 2015 Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.. 64:266-278. 2015 Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial.. 63:739-748. 2014 Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.. 63:282-290. 2014 Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.. 62:3976-3986. 2013 Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.. 62:3561-3569. 2013 Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.. 62:3218-3223. 2013 Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes.. 63:1748-1762. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.. 59:479-485.
